Recognizing and Managing ADC-Associated Pulmonary Toxicities

Editor’s Choice: Interstitial lung disease in targeted therapies: A Society of Gynecologic Oncology clinical practice statementHosted by:Jose Alejandro Rauh-Hain, MD MPHDepartment of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USAFeaturing:Charles A. Powell, MD, MBADivision of Pulmonary, Critical Care and Sleep Medicine, Tisch Cancer Center, Icahn School of Medicine at Mount Sinai, New York, NY, USACheck out more content on the journal's homepage  at https://www.gynecologiconcology-online.net